These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19124394)

  • 81. Cardiovascular genomics.
    Yoshioka J; Lee RT
    Cardiovasc Pathol; 2003; 12(5):249-54. PubMed ID: 14507573
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Microvascular medicine in Asia.
    Xiu R
    Clin Hemorheol Microcirc; 2000; 23(2-4):119-20. PubMed ID: 11321429
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The Role of Genetics in Advancing Cardiometabolic Drug Development.
    Abou-Karam R; Cheng F; Gady S; Fahed AC
    Curr Atheroscler Rep; 2024 May; 26(5):153-162. PubMed ID: 38451435
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Building a program in translational genomics.
    Hall JL
    J Cardiovasc Transl Res; 2008 Dec; 1(4):283-7. PubMed ID: 20559937
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Functional genomics and target gene validation in experimental and human disease.
    Schulte JH; Pitsch J; Becker AJ
    Drug Discov Today Technol; 2004 Oct; 1(2):105-11. PubMed ID: 24981379
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Quantitative genetics.
    Gunter C
    Nature; 2008 Dec; 456(7223):719. PubMed ID: 19079046
    [No Abstract]   [Full Text] [Related]  

  • 87. Genes and the heart: a quest for new therapeutic strategies. Cambridge Healthtech Institute's First Cardiovascular Genomics Conference. Orlando, FL, USA, 11-12 January 1999.
    Durham NP; Hall AS
    Mol Med Today; 1999 May; 5(5):195-7. PubMed ID: 10454840
    [No Abstract]   [Full Text] [Related]  

  • 88. SGLT1 and Sweet Genetic Insights Into Cardiometabolic Risk.
    Ahmad F; Li Z; Shibbani K
    J Am Coll Cardiol; 2018 Oct; 72(15):1774-1777. PubMed ID: 30286919
    [No Abstract]   [Full Text] [Related]  

  • 89. Cardiometabolic Syndrome.
    Med Econ; 2015 Aug; 92(15):49. PubMed ID: 26427177
    [No Abstract]   [Full Text] [Related]  

  • 90. The State of Cardiovascular Genomics: Abundant Data, Limited Information.
    Aslibekyan S; Ruiz-Narváez EA
    Rev Esp Cardiol (Engl Ed); 2017 Sep; 70(9):696-698. PubMed ID: 28400104
    [No Abstract]   [Full Text] [Related]  

  • 91. Preface. Genetics of cardiovascular disease.
    Chico TJ
    Prog Mol Biol Transl Sci; 2014; 124():xi-xiii. PubMed ID: 24751431
    [No Abstract]   [Full Text] [Related]  

  • 92. Expression of interleukins 7 & 8 in peripheral blood mononuclear cells from patients with metabolic syndrome: a preliminary study.
    Saidijam M; Tootoonchi AS; Goodarzi MT; Hassanzadeh T; Borzuei SH; Yadegarazari R; Shabab N
    Indian J Med Res; 2014 Aug; 140(2):238-43. PubMed ID: 25297357
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Association between leptin gene G-2548A polymorphism with metabolic syndrome.
    Hassanzadeh T; Maleki M; Saidijam M; Paoli M
    J Res Med Sci; 2013 Aug; 18(8):668-73. PubMed ID: 24379842
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The metabolic syndrome, oxidative stress, environment, and cardiovascular disease: the great exploration.
    Hutcheson R; Rocic P
    Exp Diabetes Res; 2012; 2012():271028. PubMed ID: 22829804
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Metabolic syndrome: from the genetics to the pathophysiology.
    Sookoian S; Pirola CJ
    Curr Hypertens Rep; 2011 Apr; 13(2):149-57. PubMed ID: 20957457
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Genetics of the cardiometabolic syndrome: new insights and therapeutic implications.
    Sookoian S; Pirola CJ
    Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):37-47. PubMed ID: 19124394
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Genomics of cardiovascular disease.
    Manace LC; Godiwala TN; Babyatsky MW
    Mt Sinai J Med; 2009 Dec; 76(6):613-23. PubMed ID: 20014425
    [TBL] [Abstract][Full Text] [Related]  

  • 98. New therapeutic options for the metabolic syndrome: what's next?
    Flordellis CS; Ilias I; Papavassiliou AG
    Trends Endocrinol Metab; 2005 Aug; 16(6):254-60. PubMed ID: 16002303
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
    Stahl SM; Mignon L; Meyer JM
    Acta Psychiatr Scand; 2009 Mar; 119(3):171-9. PubMed ID: 19178394
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Uncloaking the genetic determinants of metabolic syndrome.
    Lahiry P; Pollex RL; Hegele RA
    J Nutrigenet Nutrigenomics; 2008; 1(3):118-25. PubMed ID: 19776621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.